Why are Testing Rates so Low in Sub-Saharan Africa? Misconceptions and Strategic Behaviors [0.03%]
撒哈拉以南非洲的检测率为什么这么低？误解与战略性行为
Olivier Sterck
Olivier Sterck
Voluntary testing and counseling (VTC) is a popular method for fighting the HIV/AIDS epidemic. The purpose of VTC is to reduce the incidence of the virus in a two-fold manner. First, testing provides access to health care and antiretroviral...
The Effect of Pharmaceutical Innovation on Longevity: Patient Level Evidence from the 1996-2002 Medical Expenditure Panel Survey and Linked Mortality Public-use Files [0.03%]
基于医疗支出和死亡对数链接面板调查数据的药物创新对寿命的影响：患者层面的证据（1996—2002）
Frank R Lichtenberg
Frank R Lichtenberg
This study uses patient-level data to analyze the effect of technological change embodied in pharmaceuticals on the longevity of elderly Americans. Previous patient-level studies could not control for important patient attributes such as ed...
Quantifying the Value of Personalized Medicines: Evidence from COX-2 Inhibitors [0.03%]
个性化药物价值的度量：来自动脉粥样硬化和炎性治疗药物的证据
Neeraj Sood,Tomas J Philipson,Peter Huckfeldt
Neeraj Sood
We develop a conceptual framework for estimating the value of personalized medicines. We show that personalizing medicines generates value from two sources. The first is a market-expansion effect by persons who initiate treatment due to red...
Matthias Rieger
Matthias Rieger
This paper studies the relationship between civil war and HIV/AIDS in Burundi at the micro level. The case of Burundi provides interesting grounds of analysis, as seroprevalence rates are heterogeneous across the country, the serological an...
Should Global Health be Tailored Toward the Rich? Altruism and Efficient R&D for Neglected Diseases [0.03%]
全球卫生工作应针对富人吗？利他主义与被忽视疾病的高效研发
Anupam B Jena,Stéphane Mechoulan,Tomas J Philipson
Anupam B Jena
We analyze the problem of incentivizing research and development (R&D) into developing world disease from an economic efficiency perspective. We view the problem as how to best promote R&D into goods with positive external effects in the se...
Neeraj Sood,Zachary Wagner,Peter Huckfeldt et al.
Neeraj Sood et al.
We use health insurance claims data from 63 large employers to estimate the extent of price shopping for nine common outpatient services in consumer-directed health plans (CDHPs) compared to traditional health plans. The main measures of pr...
Mark A Hall,Carl E Schneider
Mark A Hall
The ultimate aim of health care policy is good care at good prices. Managed care failed to achieve this goal through influencing providers, so health policy has turned to the only market-based option left: treating patients like consumers. ...
High US Health-Care Spending and the Importance of Provider Payment Rates [0.03%]
美国高昂的医疗费用及其支付方式的重要性
Gerard Anderson,Kalipso Chalkidou,Bradley Herring
Gerard Anderson
We compare health care spending in the USA to other industrialized countries and find that payment rates for hospitals, physicians, and drugs are generally much higher in the USA than they are in other industrialized countries while the qua...
Both Symptom and Disease: Relating Medical Malpractice to Health-Care Costs [0.03%]
症状与病因兼备：医疗事故与医疗费用的关系分析
William M Sage
William M Sage
Tort reformers blame the high cost of American health care on defensive responses to rampant medical malpractice litigation. Defenders of the tort system counter that holding health care providers liable for negligence improves safety and e...
Eight Decades of Discouragement: The History of Health Care Cost Containment in the USA [0.03%]
八十载控费挫折路——美国医疗费用控制历程回顾
Timothy Stoltzfus Jost
Timothy Stoltzfus Jost
This chapter traces the history of attempts at cost control in the United States from the origins of our modern health care financing system in the 1930s and 1940s, through health care cost regulation in the 1970s, and the deregulatory 1980...